- Home
- CRBU vs EMF Comparison
CRBU vs EMF Comparison
Compare CRBU & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- EMF
- Stock Information
- Founded
- CRBU 2011
- EMF 1987
- Country
- CRBU United States
- EMF United States
- Employees
- CRBU N/A
- EMF N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- EMF Finance/Investors Services
- Sector
- CRBU Health Care
- EMF Finance
- Exchange
- CRBU Nasdaq
- EMF Nasdaq
- Market Cap
- CRBU 188.8M
- EMF 219.3M
- IPO Year
- CRBU 2021
- EMF N/A
- Fundamental
- Price
- CRBU $1.90
- EMF $14.92
- Analyst Decision
- CRBU Strong Buy
- EMF
- Analyst Count
- CRBU 4
- EMF 0
- Target Price
- CRBU $8.50
- EMF N/A
- AVG Volume (30 Days)
- CRBU 1.8M
- EMF 29.3K
- Earning Date
- CRBU 08-12-2025
- EMF 01-01-0001
- Dividend Yield
- CRBU N/A
- EMF 6.16%
- EPS Growth
- CRBU N/A
- EMF N/A
- EPS
- CRBU N/A
- EMF N/A
- Revenue
- CRBU $9,918,000.00
- EMF N/A
- Revenue This Year
- CRBU $9.52
- EMF N/A
- Revenue Next Year
- CRBU N/A
- EMF N/A
- P/E Ratio
- CRBU N/A
- EMF N/A
- Revenue Growth
- CRBU N/A
- EMF N/A
- 52 Week Low
- CRBU $0.66
- EMF $10.58
- 52 Week High
- CRBU $3.00
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- CRBU 53.41
- EMF 56.78
- Support Level
- CRBU $1.86
- EMF $14.10
- Resistance Level
- CRBU $2.13
- EMF $15.10
- Average True Range (ATR)
- CRBU 0.22
- EMF 0.19
- MACD
- CRBU -0.05
- EMF -0.05
- Stochastic Oscillator
- CRBU 15.76
- EMF 79.61
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.